Autolus Therapeutics (AUTL)
NASDAQ: AUTL
· Real-Time Price · USD
2.35
0.09 (3.98%)
At close: Jun 06, 2025, 3:59 PM
2.35
0.21%
After-hours: Jun 06, 2025, 05:43 PM EDT
Autolus Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| License Revenue | 10.12M | 1.7M | 6.19M | 1.51M | 242K |
| License Revenue Growth | +496.00% | -72.59% | +311.02% | +522.73% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 |
|---|---|
| Europe Revenue | 10.12M |
| Europe Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 29.53M | 33.68M | 27.33M | 21.9M | 16.37M | 13.95M | 10.61M | 11.12M | 9.28M | 7.41M | 8.23M | 8.27M | 7.99M | 7.59M | 8.3M | 7.24M | 8.74M | 9.01M | 9.84M | 8.51M | 7.61M | 9.92M | 8.61M | 11.37M | 9.56M | 7.59M | 7.27M | 6.8M | 4.33M | 2.89M | 2.89M | 1.66M | 1.66M |
| Selling, General, and Administrative Revenue Growth | -12.30% | +23.22% | +24.78% | +33.79% | +17.33% | +31.50% | -4.59% | +19.80% | +25.26% | -9.95% | -0.46% | +3.53% | +5.22% | -8.53% | +14.67% | -17.18% | -2.98% | -8.50% | +15.68% | +11.75% | -23.25% | +15.29% | -24.32% | +18.98% | +25.85% | +4.40% | +6.91% | +57.11% | +50.03% | 0.00% | +73.49% | 0.00% | n/a |
| Research and Development Revenue | 26.73M | 30.83M | 40.32M | 36.61M | 30.67M | 25.16M | 37.24M | 36.74M | 31.34M | 32.19M | 37.63M | 38.21M | 33.96M | 39.63M | 32.29M | 32.13M | 30.73M | 38.73M | 33.55M | 31.33M | 31.29M | 29.37M | 27.31M | 26.17M | 22.57M | 17.71M | 10.15M | 8.86M | 11.69M | 4.6M | 4.6M | 3.51M | 3.51M |
| Research and Development Revenue Growth | -13.29% | -23.54% | +10.14% | +19.37% | +21.91% | -32.44% | +1.35% | +17.22% | -2.62% | -14.47% | -1.52% | +12.51% | -14.31% | +22.74% | +0.50% | +4.56% | -20.65% | +15.45% | +7.08% | +0.13% | +6.53% | +7.54% | +4.34% | +15.99% | +27.39% | +74.53% | +14.51% | -24.20% | +154.17% | 0.00% | +31.20% | 0.00% | n/a |